Article A233232
Author(s): Safanah Siddiqui, MD, Gabriel Lutz, MD, PhD, Ali Tabatabai, MD, Rachel Nathan, MD, Megan Anders, MD, MS, Miranda Gibbons, BS, Marguerite Russo, PhD, CRNP, Sarah Whitehead, CRNP, Peter Rock, MD, MBA, Thomas Scalea, MD, and Raya E. Kheirbek, MD, MPH
Contact Hours 1.00
CERP B 1.00
Expires May 01, 2026
Topics: COVID-19, ECMO, Family-Centered Care, Palliative/End-of-life Care
Population: Geriatric, Adult
Required reading for all learners: Implicit Bias impacts patient outcomes
Extracorporeal membrane oxygenation (ECMO) is used as a bridge to recovery in patients with acute reversible conditions, to transplantation in patients with irreversible cardiac or respiratory failure, and to ventricular assist device therapy in some patients with cardiac failure. The World Health Organization has recommended considering the use of ECMO for patients with COVID-19 hypoxemia refractory to mechanical ventilatory support. Given the critical frailty of patients who require the complex support that ECMO provides, realistically managing families’ expectations for potential recovery can be difficult. This difficulty increases as time passes for patients receiving ECMO whose clinical status fails to improve. Palliative care supports seriously ill patients and their families with high-level communication and symptom management skills. Studies have shown that palliative care consultation improves the quality and quantity of communication with family members.Learners must complete the entire activity and the associated evaluation to be awarded contact hours AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.
AccreditationThe American Association of Critical-Care Nurses is accredited as a provider of
nursing continuing professional development by the American Nurses Credentialing Center's Commission on
Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for
{contactHours} contact hours.
Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.
Accreditation refers to recognition of continuing education only and does not imply AACN, ANCC, or CBRN approval or endorsement of any commercial products discussed or displayed in conjunction with this educational activity. Activities with pharmacology hours are to assist the APRN in fulfilling the pharmacotherapeutic education requirements for licensure and certification renewals.
Activities meet the standards for most states that require mandatory continuing education for license and/or certification renewal. AACN recommends consulting with your own state board of nursing or credentialing organization before submitting your certificate of completion.
Refund PolicyContinuing Education Activities are nonrefundable.